JUNS Raises $2 Million in Registered Direct Offering, Strengthening CNS Drug Pipeline
Market Chameleon (Thu, 21-May 10:32 AM)
Jupiter Neurosciences Secures Exclusive U.S. Rights to ALA-002 in $100 Million+ Deal—Strategic Partnership Expands Mental Health Pipeline
Market Chameleon (Wed, 20-May 9:51 AM)
